How many times a day should I check my blood glucose levels while taking 70/30 (Novolin 70/30, insulin NPH/insulin regular)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blood Glucose Monitoring Frequency with 70/30 Insulin

If you are taking 70/30 insulin (Novolin 70/30), you should check your blood glucose at least 4 times per day: before breakfast, before dinner, at bedtime, and when you suspect low blood sugar. 1

Recommended Testing Schedule

Minimum Daily Testing Points

  • Before breakfast (fasting) - to assess overnight glucose control and guide morning dose adjustments 1
  • Before dinner - to evaluate daytime glucose control and guide evening dose adjustments 1
  • At bedtime - to prevent nocturnal hypoglycemia, which is a particular risk with premixed insulins 1
  • When you suspect low blood sugar - premixed insulins like 70/30 carry significant hypoglycemia risk 2, 3

Additional Testing Situations

  • After treating low blood sugar - continue testing until glucose normalizes 1
  • Before exercise - to prevent exercise-induced hypoglycemia 1
  • Before critical tasks like driving - to ensure safety 1

Why This Frequency Matters

The American Diabetes Association specifically recommends that people using multiple daily insulin injections perform blood glucose monitoring at least 4 times daily, as this frequency has been strongly associated with better glycemic control (lower A1C levels) across all age groups 1. Testing less than 3-4 times daily in insulin-treated patients has been linked to worse glucose control 1.

With 70/30 insulin specifically, frequent monitoring is even more critical because this premixed formulation contains both intermediate-acting (NPH) and short-acting (regular) insulin components, creating multiple peak action times throughout the day when hypoglycemia risk is highest 4, 2.

Key Monitoring Targets

  • Fasting glucose goal: 90-130 mg/dL 1, 2
  • Peak postprandial glucose: <180 mg/dL 1
  • Adjust your evening dose if more than 50% of fasting readings are above target 2
  • Reduce your dose by 2 units if you have more than 2 low readings per week 2

Critical Safety Considerations

Common Pitfalls to Avoid

  • Never skip bedtime testing - nocturnal hypoglycemia is particularly common with 70/30 insulin due to the NPH component's overnight action 1, 5
  • Don't rely solely on fasting glucose - you need pre-dinner readings to properly adjust your morning dose 2, 3
  • Maintain consistent meal timing - 70/30 insulin requires eating 30 minutes after injection, and skipping or delaying meals significantly increases hypoglycemia risk 2, 3

When to Test More Frequently

During dose adjustments or regimen changes, you should monitor even more frequently - the guidelines recommend evaluation every 2 weeks with adjustments as needed 2. If you're experiencing frequent hypoglycemia or your glucose control is unstable, increase testing frequency beyond the minimum 4 times daily 1.

Why Not Less Frequent Testing?

Studies demonstrate that testing fewer than 4 times daily in insulin-treated patients results in higher A1C levels and increased risk of both severe hyperglycemia and undetected hypoglycemia 1. The fixed 70/30 ratio provides less flexibility than separate basal-bolus regimens, making frequent monitoring essential to detect patterns and prevent complications 2, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Premixed Insulin Regimens

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insulin Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Insulin Regimen Conversion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.